Lista de obras -

A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33-35 weeks of gestational age, based on data from the Spanish FLIP Study

artículo científico publicado en 2008

An update on respiratory syncytial virus epidemiology: a developed country perspective

artículo científico publicado en 2002

Anaemia of prematurity: treatment with erythropoietin ⬇️

artículo científico publicado el 1 de noviembre de 2001

Attempt to normalize simulated exhaled nitric oxide according to ventilatory settings.

artículo científico publicado en 2008

Blood ammonia and transaminases in full term infants suffering from perinatal asphyxia

artículo científico publicado en 2003

Blood extractions, transfusion policy and erythropoietin in the newborn

artículo científico publicado el 1 de julio de 1998

Burden of Severe Respiratory Syncytial Virus Disease Among 33-35 Weeks' Gestational Age Infants Born During Multiple Respiratory Syncytial Virus Seasons.

artículo científico publicado en 2017

Burden of respiratory syncytial virus hospitalisation among infants born at 32-35 weeks' gestational age in the Northern Hemisphere: pooled analysis of seven studies

artículo científico publicado en 2020

Can we improve the targeting of respiratory syncytial virus (RSV) prophylaxis in infants born 32-35 weeks' gestational age with more informed use of risk factors?

artículo científico publicado en 2014

Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain

artículo científico publicado en 2004

Challenges in the prevention or treatment of RSV with emerging new agents in children from low- and middle-income countries

artículo científico publicado en 2020

Clinical Endpoints for Respiratory Syncytial Virus Prophylaxis Trials in Infants and Children in High-income and Middle-income Countries

artículo científico publicado en 2015

Clinical relevance of prevention of respiratory syncytial virus lower respiratory tract infection in preterm infants born between 33 and 35 weeks gestational age.

artículo científico publicado en 2008

Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain.

artículo científico publicado en 2017

Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries

artículo científico publicado en 2016

Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Children with Chronic Diseases

artículo científico publicado en 2017

Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Chronic Lung Disease

artículo científico publicado en 2016

Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Congenital Heart Disease

artículo científico publicado en 2017

Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart Disease

artículo científico publicado en 2016

Development and validation of a risk scoring tool to predict respiratory syncytial virus hospitalization in premature infants born at 33 through 35 completed weeks of gestation

artículo científico publicado en 2008

Differences in fat content and fatty acid proportions among colostrum, transitional, and mature milk from women delivering very preterm, preterm, and term infants

artículo científico publicado en 2010

Early administration of the second dose of surfactant (beractant) in the treatment of severe hyaline membrane disease

artículo científico publicado en 2001

Editorial

artículo científico publicado en 2007

Effect of maternal clinical chorioamnionitis on neonatal morbidity in very-low birthweight infants: a case-control study

artículo científico publicado en 2010

Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants ⬇️

artículo científico publicado el 1 de septiembre de 2003

Effects of parental and household smoking on the risk of respiratory syncytial virus (RSV) hospitalisation in late-preterm infants and the potential impact of RSV prophylaxis ⬇️

artículo científico publicado el 12 de febrero de 2013

Efficacy of three treatment schedules in severe meconium aspiration syndrome

artículo científico publicado en 2004

Erythropoietin and prematurity--where do we stand?

artículo científico publicado en 2005

European risk factors' model to predict hospitalization of premature infants born 33-35 weeks' gestational age with respiratory syncytial virus: validation with Italian data

artículo científico publicado en 2010

Expert consensus on palivizumab use for respiratory syncytial virus in developed countries

artículo científico publicado en 2018

Exploring respiratory syncytial virus prophylaxis for children with all grades of bronchopulmonary dysplasia

artículo científico publicado en 2020

Extrauterine growth restriction in very preterm infant: etiology, diagnosis, and 2-year follow-up

artículo científico publicado en 2020

FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks

artículo científico publicado en 2008

Guideline for the use of antenatal corticosteroids for fetal maturation

artículo científico publicado en 2008

Guidelines on CMV congenital infection

artículo científico publicado en 2009

Health economics and RSV.

scientific article published on June 2009

High risk for RSV bronchiolitis in late preterms and selected infants affected by rare disorders: a dilemma of specific prevention ⬇️

artículo científico publicado el 1 de mayo de 2012

Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive seasons ⬇️

artículo científico publicado el 1 de septiembre de 2001

Identifying risk factors for severe respiratory syncytial virus among infants born after 33 through 35 completed weeks of gestation: different methodologies yield consistent findings

artículo científico publicado en 2004

Impact of chorioamnionitis on exhaled nitric oxide and endotracheal aspirate levels of nitrites–nitrates and interleukin‐8 in mechanically ventilated preterm neonates ⬇️

artículo científico publicado el 18 de enero de 2011

Impact of severe disease caused by respiratory syncytial virus in children living in developed countries

artículo científico publicado en 2003

Interaction between healthcare professionals and parents is a key determinant of parental distress during childhood hospitalisation for respiratory syncytial virus infection (European RSV Outcomes Study [EROS]).

artículo científico publicado en 2018

Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference.

artículo científico publicado en 2014

Intravenous immunoglobulin and necrotizing enterocolitis in newborns with hemolytic disease

artículo científico publicado en 2009

Introduction. RSV and RAD: possibilities for prevention? The link between respiratory syncytial virus and reactive airway disease

artículo científico publicado en 2002

Invasive catheters in neonates

scientific article published on 01 October 1999

Long-Term Burden and Respiratory Effects of Respiratory Syncytial Virus Hospitalization in Preterm Infants-The SPRING Study

artículo científico publicado en 2015

Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial

artículo científico publicado en 2009

Neonatal Salmonella enteritidis infection

artículo científico publicado en 1993

Neonatal convulsions and subarachnoid hemorrhage after in utero exposure to paroxetine

artículo científico publicado el 16 de abril de 2003

Nonimmune hydrops fetalis due to congenital xerocytosis

scientific article published on 01 January 2005

Palivizumab outcomes registry data from Spain: Infección Respiratoria Infantil por Virus Respiratorio Sincitial (IRIS) Study Group

artículo científico publicado en 2003

Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing

artículo científico publicado en 2007

Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children

artículo científico publicado en 2018

Plasma endothelin-1 and clinical manifestations of neonatal sepsis

scientific article published on 01 January 2004

Plasma nitrite/nitrate and endothelin-1 concentrations in neonatal sepsis

artículo científico publicado en 2003

Population based external validation of a European predictive model for respiratory syncytial virus hospitalization of premature infants born 33 to 35 weeks of gestational age

artículo científico publicado en 2010

Probable early-onset group B streptococcal neonatal sepsis: a serious clinical condition related to intrauterine infection

artículo científico publicado en 2008

RSV prevention in infancy and asthma in later life

artículo científico publicado en 2018

Recommendations for the prevention of respiratory syncytial virus infections. Standards Committee of the Spanish Society of Neonatology. Board of Directors of the Spanish Society of Neonatology

scientific article published on 01 April 2000

Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation: a prospective study. IRIS Study Group

artículo científico publicado en 2000

Respiratory syncytial virus prophylaxis for children with chronic lung disease: have we got the criteria right?

artículo científico publicado en 2019

Risk and outcome factors in necrotizing enterocolitis

artículo científico publicado en 1996

Risk scoring tool to predict respiratory syncytial virus hospitalisation in premature infants

artículo científico publicado en 2018

Serum soluble ICAM-1, VCAM-1, L-selectin, and P-selectin levels as markers of infection and their relation to clinical severity in neonatal sepsis

scientific article published on 12 June 2007

The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood

artículo científico publicado en 2017

The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children

artículo científico publicado en 2010

The effects of varying protein and energy intakes on the growth and body composition of very low birth weight infants

artículo científico publicado en 2011

The impact of clinical maternal chorioamnionitis on neurological and psychological sequelae in very-low-birth weight infants: a case-control study ⬇️

artículo científico publicado el 7 de febrero de 2011

The influence of birth weight amongst 33-35 weeks gestational age (wGA) infants on the risk of respiratory syncytial virus (RSV) hospitalisation: a pooled analysis

artículo científico publicado en 2016

Timing of umbilical cord clamping: new thoughts on an old discussion.

artículo científico publicado en 2010

Treatment and prevention of malaria in pregnancy and newborn

artículo científico publicado en 2008

Trends in survival among extremely-low-birth-weight infants (less than 1000 g) without significant bronchopulmonary dysplasia

artículo científico publicado en 2012

Validation of a model to predict hospitalization due to RSV of infants born at 33-35 weeks' gestation

artículo científico publicado en 2010

[Agenesis of the trachea: apropos of a case]

artículo científico publicado en 1988

[Changes in homecare for preterm and low-birth-weight infants from 2002 to 2014]

artículo científico publicado en 2016

[Early onset of neonatal sepsis due to Streptococcus agalactiae: study of ten years (1985-1994) and the utility of intrapartum prophylaxis]

scientific article published on 01 March 1997

[Guidelines for respiratory syncytial virus prophylaxis. An update]

artículo científico publicado en 2002

[Hyperbilirubinemia in full-term newborns. Predictive factors]

scientific article published on 01 April 1999

[Influence of in-home nursing care on the weight of the early discharged preterm newborn]

artículo científico publicado en 2014

[Intracerebellar hemorrhage in full-term newborns. Importance of transfontanellar echography. Apropos of a case]

scientific article published on 01 May 1989

[Percutaneous microcatheters: experience in a neonatal pathology center]

artículo científico publicado en 1987

[Plasmacoagulase-negative Staphylococcus sepsis: experience in a neonatal intensive care unit]

artículo científico publicado en 1987

[Prevention of adverse effects related to ophthalmological examination in premature infants]

scientific article published on 01 February 2004

[Quality of life of preterm infants and admissions due to respiratory infections]

scientific article published on 16 December 2009

[Recommendations for the use of palivizumab in the prevention of respiratory syncytial virus infection in late preterm infants (32(1) to 35(0) weeks of gestation)]

artículo científico publicado en 2010

[Severe infection caused by Candida parapsilosis in an infant]

artículo científico publicado en 1990

[Update of recommendations on the use of palivizumab as prophylaxis in RSV infections]

artículo científico publicado en 2014

[Usefulness of erythropoietin in the treatment of anemia of prematurity. Influence of birth weight]

artículo científico publicado en 1999

Tratamiento con eritropoyetina para la anemia tardía tras enfermedad hemolítica del recién nacido ⬇️

artículo científico publicado el 20 de octubre de 2010

Lista de obras de

A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33-35 weeks of gestational age, based on data from the Spanish FLIP Study

An update on respiratory syncytial virus epidemiology: a developed country perspective

Anaemia of prematurity: treatment with erythropoietin ⬇️

Attempt to normalize simulated exhaled nitric oxide according to ventilatory settings.

Blood ammonia and transaminases in full term infants suffering from perinatal asphyxia

Blood extractions, transfusion policy and erythropoietin in the newborn

Burden of Severe Respiratory Syncytial Virus Disease Among 33-35 Weeks' Gestational Age Infants Born During Multiple Respiratory Syncytial Virus Seasons.

Burden of respiratory syncytial virus hospitalisation among infants born at 32-35 weeks' gestational age in the Northern Hemisphere: pooled analysis of seven studies

Can we improve the targeting of respiratory syncytial virus (RSV) prophylaxis in infants born 32-35 weeks' gestational age with more informed use of risk factors?

Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain

Challenges in the prevention or treatment of RSV with emerging new agents in children from low- and middle-income countries

Clinical Endpoints for Respiratory Syncytial Virus Prophylaxis Trials in Infants and Children in High-income and Middle-income Countries

Clinical relevance of prevention of respiratory syncytial virus lower respiratory tract infection in preterm infants born between 33 and 35 weeks gestational age.

Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain.

Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries

Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Children with Chronic Diseases

Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Chronic Lung Disease

Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Congenital Heart Disease

Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart Disease

Development and validation of a risk scoring tool to predict respiratory syncytial virus hospitalization in premature infants born at 33 through 35 completed weeks of gestation

Differences in fat content and fatty acid proportions among colostrum, transitional, and mature milk from women delivering very preterm, preterm, and term infants

Early administration of the second dose of surfactant (beractant) in the treatment of severe hyaline membrane disease

Editorial

Effect of maternal clinical chorioamnionitis on neonatal morbidity in very-low birthweight infants: a case-control study

Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants ⬇️

Effects of parental and household smoking on the risk of respiratory syncytial virus (RSV) hospitalisation in late-preterm infants and the potential impact of RSV prophylaxis ⬇️

Efficacy of three treatment schedules in severe meconium aspiration syndrome

Erythropoietin and prematurity--where do we stand?

European risk factors' model to predict hospitalization of premature infants born 33-35 weeks' gestational age with respiratory syncytial virus: validation with Italian data

Expert consensus on palivizumab use for respiratory syncytial virus in developed countries

Exploring respiratory syncytial virus prophylaxis for children with all grades of bronchopulmonary dysplasia

Extrauterine growth restriction in very preterm infant: etiology, diagnosis, and 2-year follow-up

FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks

Guideline for the use of antenatal corticosteroids for fetal maturation

Guidelines on CMV congenital infection

Health economics and RSV.

High risk for RSV bronchiolitis in late preterms and selected infants affected by rare disorders: a dilemma of specific prevention ⬇️

Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive seasons ⬇️

Identifying risk factors for severe respiratory syncytial virus among infants born after 33 through 35 completed weeks of gestation: different methodologies yield consistent findings

Impact of chorioamnionitis on exhaled nitric oxide and endotracheal aspirate levels of nitrites–nitrates and interleukin‐8 in mechanically ventilated preterm neonates ⬇️

Impact of severe disease caused by respiratory syncytial virus in children living in developed countries

Interaction between healthcare professionals and parents is a key determinant of parental distress during childhood hospitalisation for respiratory syncytial virus infection (European RSV Outcomes Study [EROS]).

Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference.

Intravenous immunoglobulin and necrotizing enterocolitis in newborns with hemolytic disease

Introduction. RSV and RAD: possibilities for prevention? The link between respiratory syncytial virus and reactive airway disease

Invasive catheters in neonates

Long-Term Burden and Respiratory Effects of Respiratory Syncytial Virus Hospitalization in Preterm Infants-The SPRING Study

Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial

Neonatal Salmonella enteritidis infection

Neonatal convulsions and subarachnoid hemorrhage after in utero exposure to paroxetine

Nonimmune hydrops fetalis due to congenital xerocytosis

Palivizumab outcomes registry data from Spain: Infección Respiratoria Infantil por Virus Respiratorio Sincitial (IRIS) Study Group

Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing

Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children

Plasma endothelin-1 and clinical manifestations of neonatal sepsis

Plasma nitrite/nitrate and endothelin-1 concentrations in neonatal sepsis

Population based external validation of a European predictive model for respiratory syncytial virus hospitalization of premature infants born 33 to 35 weeks of gestational age

Probable early-onset group B streptococcal neonatal sepsis: a serious clinical condition related to intrauterine infection

RSV prevention in infancy and asthma in later life

Recommendations for the prevention of respiratory syncytial virus infections. Standards Committee of the Spanish Society of Neonatology. Board of Directors of the Spanish Society of Neonatology

Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation: a prospective study. IRIS Study Group

Respiratory syncytial virus prophylaxis for children with chronic lung disease: have we got the criteria right?

Risk and outcome factors in necrotizing enterocolitis

Risk scoring tool to predict respiratory syncytial virus hospitalisation in premature infants

Serum soluble ICAM-1, VCAM-1, L-selectin, and P-selectin levels as markers of infection and their relation to clinical severity in neonatal sepsis

The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood

The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children

The effects of varying protein and energy intakes on the growth and body composition of very low birth weight infants

The impact of clinical maternal chorioamnionitis on neurological and psychological sequelae in very-low-birth weight infants: a case-control study ⬇️

The influence of birth weight amongst 33-35 weeks gestational age (wGA) infants on the risk of respiratory syncytial virus (RSV) hospitalisation: a pooled analysis

Timing of umbilical cord clamping: new thoughts on an old discussion.

Treatment and prevention of malaria in pregnancy and newborn

Trends in survival among extremely-low-birth-weight infants (less than 1000 g) without significant bronchopulmonary dysplasia

Validation of a model to predict hospitalization due to RSV of infants born at 33-35 weeks' gestation

[Agenesis of the trachea: apropos of a case]

[Changes in homecare for preterm and low-birth-weight infants from 2002 to 2014]

[Early onset of neonatal sepsis due to Streptococcus agalactiae: study of ten years (1985-1994) and the utility of intrapartum prophylaxis]

[Guidelines for respiratory syncytial virus prophylaxis. An update]

[Hyperbilirubinemia in full-term newborns. Predictive factors]